| General Information | |||
|---|---|---|---|
| Term | French Canadian Leigh disease | ID (Ontology) | DOID:0111180 (Human Disease) |
| Definition | A cytochrome-c oxidase deficiency disease characterized by metabolic and/or neurological crises, chronic hyperlactataemia, hypotonia, ataxia, mild facial dysmorphism, delayed development and development of lesions in the brainstem and basal ganglia that has_material_basis_in homozygous or compound heterozygous mutations in LRPPRC on 2p21. | ||
| Also Known As | "French Canadian type COX deficiency" ; "French Canadian type cytochrome c oxidase deficiency" ; "French Canadian type Leigh syndrome" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
mitochondrial metabolism disease |__cytochrome-c oxidase deficiency disease |__French Canadian Leigh disease 5 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | cytochrome-c oxidase deficiency disease | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:8370 MESH:C537004 MIM:220111 ORDO:70472 SNOMEDCT_US_2023_03_01:718219002 UMLS_CUI:C1857355 |
|||